CR8883A - DIRECTED ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE AND PROCEDURES USING THE SAME - Google Patents

DIRECTED ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE AND PROCEDURES USING THE SAME

Info

Publication number
CR8883A
CR8883A CR8883A CR8883A CR8883A CR 8883 A CR8883 A CR 8883A CR 8883 A CR8883 A CR 8883A CR 8883 A CR8883 A CR 8883A CR 8883 A CR8883 A CR 8883A
Authority
CR
Costa Rica
Prior art keywords
procedures
same
peptide
antibodies against
amyloid peptide
Prior art date
Application number
CR8883A
Other languages
Spanish (es)
Inventor
Rosenthal Arnon
Pons Jaume
Ho Wei-Hsien
Markus Grimm Jan
Original Assignee
Rinat Neuroscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rinat Neuroscience Corp filed Critical Rinat Neuroscience Corp
Publication of CR8883A publication Critical patent/CR8883A/en

Links

Abstract

Se describen un annticuerpo monoclonal 9TL y anticuerpos obtenidos de 9TL dirigidos contra peptido beta-amiliode y procedimientos para usar los mismos para el diagnostico y tratamiento de la enfermedad de Alzheimer y enfermedades asociadas a peptido AB.Tambien se describen procedimientos para usar anticuerpos dirigidos contra peptido amiloide-beta que tienen la funcion efectora alterada para el tratamiento de la enfermedad de Alzheimer y enfermedades asociadas a peptido ABA 9TL monoclonal antibody and antibodies obtained from 9TL directed against beta-amiliode peptide and methods for using them for the diagnosis and treatment of Alzheimer's disease and diseases associated with AB peptide are also described. Methods for using antibodies directed against peptide are also described. amyloid-beta that have impaired effector function for the treatment of Alzheimer's disease and diseases associated with AB peptide

CR8883A 2004-07-30 2007-01-29 DIRECTED ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE AND PROCEDURES USING THE SAME CR8883A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US56249404P 2004-07-30 2004-07-30
US65319705P 2005-02-14 2005-02-14
US67609305P 2005-04-29 2005-04-29

Publications (1)

Publication Number Publication Date
CR8883A true CR8883A (en) 2007-04-26

Family

ID=44839355

Family Applications (1)

Application Number Title Priority Date Filing Date
CR8883A CR8883A (en) 2004-07-30 2007-01-29 DIRECTED ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE AND PROCEDURES USING THE SAME

Country Status (1)

Country Link
CR (1) CR8883A (en)

Similar Documents

Publication Publication Date Title
NI200700021A (en) DIRECTED ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE AND PROCEDURES USING THE SAME. PC19496A
MX2007013626A (en) Antibodies directed against amyloid-beta peptide and methods using same.
UY29282A1 (en) HUMANIZED ANTIBODIES RECOGNIZING THE BETA AMYLOID PEPTIDE
UY28337A1 (en) HUMANIZED ANTIBODIES RECOGNIZING THE BETA AMILOID PEPTIDE
CY1112277T1 (en) HUMANIZED ANTI-β7 COMPETITORS AND THEIR USES
CY1110963T1 (en) HUMANITIZED ANTIBODIES RECOGNIZING BETA AMYLOID Peptide
UY27062A1 (en) HUMANIZED ANTIBODIES RECOGNIZING THE BETA AMYLOID PEPTIDE
UY27721A1 (en) HUMANIZED ANTIBODIES RECOGNIZING THE BETA AMYLOID PEPTIDE.
UY29284A1 (en) AB (BETA) HUMANIZED ANTIBODIES USED TO IMPROVE COGNITION
ATE549033T1 (en) THERAPEUTIC HUMAN MONOCLONAL ANTI-IL-1R1 ANTIBODY
BR0315157A (en) Methods of treating alzheimer's disease by employing antibodies directed against amyloid beta peptide and compositions thereof
BRPI0414513A (en) kid3 and kid3 antibodies that bind to it
CR8108A (en) TREATMENT WITH ANTI-VEGF ANTIBODIES
AR051800A1 (en) BETA ANTIBODIES USED TO IMPROVE COGNITION
BR0310088A (en) Drug pre-targeting by bispecific antibodies and haptenic constructs comprising a peptide vehicle and the active agent (s)
DK1734995T3 (en) Monoclonal antibodies and hepatocyte growth factor
DK1641828T3 (en) Anti-HGF-R antibodies and their use
DK1553985T3 (en) Biphenyls as imaging agents in Alzheimer's disease
CR8883A (en) DIRECTED ANTIBODIES AGAINST BETA-AMYLOID PEPTIDE AND PROCEDURES USING THE SAME
AR055072A1 (en) USE OF ANTI-MADCAM ANTIBODIES FOR THE TREATMENT OF CELIAC DISEASE AND TROPICAL ESPRUE
IL185653A0 (en) Pharmaceutical compositions containing an antibody which binds the stalk region of kim-1
CU23668A3 (en) ANTIBODIES DIRECTED AGAINST THE BETA-AMYLOID PEPTIDE AND METHODS OF USING THE SAME